RESUMEN
alpha2-Adrenergic receptors (alpha2ARs) present in the brainstem decrease blood pressure and are targets for clinically effective antihypertensive drugs. The existence of three alpha2AR subtypes, the lack of subtype-specific ligands, and the cross-reactivity of alpha2AR agonists with imidazoline receptors has precluded an understanding of the role of individual alpha2AR subtypes in the hypotensive response. Gene targeting was used to introduce a point mutation into the alpha2aAR subtype in the mouse genome. The hypotensive response to alpha2AR agonists was lost in the mutant mice, demonstrating that the alpha2aAR subtype plays a principal role in this response.
Asunto(s)
Presión Sanguínea/fisiología , Receptores Adrenérgicos alfa 2/fisiología , Agonistas de Receptores Adrenérgicos alfa 2 , Agonistas alfa-Adrenérgicos/farmacología , Animales , Antihipertensivos/farmacología , Secuencia de Bases , Presión Sanguínea/efectos de los fármacos , Tronco Encefálico/fisiología , Tartrato de Brimonidina , Marcación de Gen , Frecuencia Cardíaca/efectos de los fármacos , Frecuencia Cardíaca/fisiología , Imidazoles/farmacología , Medetomidina , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Mutación Puntual , Quinoxalinas/farmacología , Receptores Adrenérgicos alfa 2/genética , Receptores Adrenérgicos alfa 2/metabolismoRESUMEN
This manuscript is intended to provide a comprehensive review of the alpha-adrenoceptors (ARs) and their role in vascular regulation. The historical development of the concept of receptors and the division of the alpha-ARs into alpha 1 and alpha 2 subtypes is traced. Emphasis will be placed on current understanding of the specific contribution of discrete alpha 1- and alpha 2-AR subtypes in the regulation of the vasculature, selective agonists and antagonists for these receptors, the second messengers utilized by these receptors, the myoplasmic calcium pathways activated to initiate smooth muscle contraction, as well as the clinical uses of agonists and antagonists that work at these receptors. New information is presented that deals with the molecular aspects of ligand interactions with specific subdomains of these receptors, as well as mRNA distribution and the regulation of alpha 1- and alpha 2-AR gene transcription and translation.
Asunto(s)
Músculo Liso Vascular/fisiología , Receptores Adrenérgicos alfa/fisiología , Clonación Molecular , Proteínas de Unión al GTP/metabolismo , Humanos , Tono Muscular , Músculo Liso Vascular/efectos de los fármacos , Unión Proteica , Receptores Adrenérgicos alfa/clasificación , Receptores Adrenérgicos alfa/efectos de los fármacos , Receptores Adrenérgicos alfa/genética , Receptores Adrenérgicos alfa/metabolismo , Sistemas de Mensajero Secundario , Transducción de SeñalRESUMEN
This review is intended to discuss recent developments in the molecular pharmacology of the alpha 1-adrenergic receptor (alpha 1-AR) subtypes. After a brief historical development, we will focus on the more contemporary issues having to do with this receptor family. Emphasis will be put on recent data regarding the cloning, nomenclature, signalling mechanisms, and genomic organization of the alpha 1-AR subtypes. We will also highlight recent mutational studies that identify key amino acid residues involved in ligand binding, as well as the role of the alpha 1-AR subtypes in regulating physiologic processes.
Asunto(s)
Receptores Adrenérgicos alfa 1 , Envejecimiento , Animales , Clonación Molecular , Proteínas de Unión al GTP/metabolismo , Regulación de la Expresión Génica , Humanos , Ligandos , Modelos Moleculares , ARN Mensajero , Receptores Adrenérgicos alfa 1/química , Receptores Adrenérgicos alfa 1/genética , Receptores Adrenérgicos alfa 1/metabolismo , Fracciones Subcelulares , Distribución Tisular , Transcripción GenéticaRESUMEN
The synthesis and pharmacological activity of erythro and threo isomers of 1-(3',4',5'-trimethoxy-alpha-hydroxy-benzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, 2 and 3, are reported. The structural assignments of 2 and 3 are based upon NMR spectra of the 6,7-dibenzyl precursors, 6 and 10, and of the synthetic derivatives of 13alpha- and 13beta-hydroxy-2,3-(dibenzyloxy)-9,10,11-trimethoxytetrahydroprotoberberine, 8 and 12, respectively. The erythro isomer 2 was a more potent beta-adrenoceptor stimulant than the threo isomer 3 in guinea pig atrial, guinea pig tracheal, and rat adipocyte preparations. The differential activity of these compounds on lipolysis was favorably correlated to changes in the stimulation of adenylate cyclase activity and cAMP accumulation in rat adipocytes.
Asunto(s)
Agonistas Adrenérgicos beta/síntesis química , Isoquinolinas/síntesis química , Tretoquinol/síntesis química , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Resistencia de las Vías Respiratorias/efectos de los fármacos , Animales , AMP Cíclico/metabolismo , Femenino , Cobayas , Frecuencia Cardíaca/efectos de los fármacos , Técnicas In Vitro , Metabolismo de los Lípidos , Espectroscopía de Resonancia Magnética , Masculino , Ratas , Estereoisomerismo , Tretoquinol/análogos & derivados , Tretoquinol/farmacologíaRESUMEN
The very close interdependence of Ca2+ and hormones in the overall metabolism of cyclic nucleotides has recently been emphasized by Cheung. Clearly the results presented here show that [Ca2+] in the physiological range (less than 10(-7) M to greater than 10(-6) M) has profound effects on the activity of adenylate cyclase from both brain and cardiac muscle. Whereas both brain and cardiac cyclase exhibit a Ca2+ dependent inhibition (perhaps mediated by calmodulin), only the brain cyclase is activated by Ca2+ via calmodulin. With both cyclases there is an inverse relationship between the inhibition of cyclase and the activation of calmodulin dependent (cAMP and cGMP) phosphodiesterase as a function of Ca2+ concentration. Because the IC50's for Ca2+ are the same in both heart and brain, the possibility exists that the Ca2+ inhibitory site of both cyclases is similar and perhaps identical. Considering the ability of Ca2+ to both stimulate and inhibit cyclase, one could imagine that in different species, tissues, or regions of the same tissue, there could exist multiple populations of cyclase, that is a cyclase which would only show Ca2+ dependent inhibition, Ca2+ dependent stimulation, or the biphasic response to Ca2+ (FIGURE 7). The fact that Ca2+ still regulates adenylate cyclase after various stimuli (histamine, NaF, etc.) suggests that Ca2+ may function to regulate the cyclase over shorter time periods (regardless of its state of stimulation) and that other affectors of cyclase (e.g., hormones) would serve to regulate the cyclase over longer time periods.
Asunto(s)
Adenilil Ciclasas/metabolismo , Encéfalo/enzimología , Calcio/farmacología , Miocardio/enzimología , 3',5'-AMP Cíclico Fosfodiesterasas/metabolismo , 3',5'-GMP Cíclico Fosfodiesterasas/metabolismo , Animales , Calmodulina/metabolismo , Cationes Bivalentes , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 1 , Activación Enzimática , Cobayas , Cinética , Trifluoperazina/farmacología , Troponina/farmacología , Troponina I , Tirosina/análisisRESUMEN
The effect of chlorethylclonidine on alpha 1-adrenoceptor subtypes and arterial blood pressure has been evaluated. Chlorethylclonidine significantly reduced the alpha 1-adrenoceptor population. Chlorethylclonidine treatment had no significant effect on resting systemic arterial blood pressure or heart rate and shifted the phenylephrine pressor dose-response curve only 2.4-fold to the right. These data suggest that only one of the alpha 1-adrenoceptor subtypes plays a major role in the regulation of arterial blood pressure.
Asunto(s)
Presión Sanguínea/efectos de los fármacos , Receptores Adrenérgicos alfa/efectos de los fármacos , Anestesia , Animales , Aorta Torácica/efectos de los fármacos , Sitios de Unión , Clonidina/análogos & derivados , Clonidina/farmacología , Relación Dosis-Respuesta a Droga , Frecuencia Cardíaca/efectos de los fármacos , Técnicas In Vitro , Masculino , Fenilefrina/farmacología , Prazosina/metabolismo , Ratas , Ratas Endogámicas , Receptores Adrenérgicos alfa/fisiologíaRESUMEN
The peripheral hemodynamic effects of SZL-49, a prazosin analog capable of selectively inactivating the alpha 1a-adrenoceptor subtype, was evaluated in the conscious rat. One hour after SZL-49 administration, total peripheral vascular resistance and arterial blood pressure significantly decreased and cardiac output and heart rate increased. Twenty-four hours after SZL-49, blood pressure returned to control preinjection levels while peripheral resistance remained decreased and cardiac output and heart rate were elevated. The phenylephrine dose-response curves for mean arterial blood pressure and total peripheral vascular resistance were shifted to the right but the maximal responses were not decreased. These data show that the alpha 1a receptor plays a role in the tonic maintenance of arterial blood pressure. The alpha 1b receptor appears to participate in the response to exogenously administered agonists.
Asunto(s)
Antagonistas Adrenérgicos alfa/farmacología , Hemodinámica/efectos de los fármacos , Prazosina/análogos & derivados , Receptores Adrenérgicos alfa/fisiología , Anestesia , Animales , Presión Sanguínea/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Clorisondamina/farmacología , Relación Dosis-Respuesta a Droga , Masculino , Fenilefrina/farmacología , Prazosina/farmacología , Ratas , Ratas Endogámicas , Receptores Adrenérgicos alfa/efectos de los fármacos , Resistencia Vascular/efectos de los fármacosRESUMEN
In selected beta1- (heart, lipolysis) and beta2-adrenoceptor (trachea) systems, the interaction of racemic-trimetoquinol (TMQ) and the erythro- and threo-diastereomers of 1-(3',4',5'-trimethoxy-alpha-hydroxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (alpha-hydroxy TMQ) was investigated. Each tetrahydroisoquinoline possessed agonist activity in these beta-adrenoceptor systems. The rank order of potency observed for these compounds was racemic-TMQ greater than erythro-alpha-hydroxy TMQ greater than threo-alpha-hydroxy TMQ. Using isolated fat adipocytes, a favorable correlation was observed between the elevation in c-AMP and pharmacological response for the TMQ stereoisomers and diastereomers of alpha-hydroxy TMQ. The rise in intracellular c-AMP produced by (-)- and (+)-TMQ in fat cells was blocked by the presence of propranolol, and not in the presence of phentolamine. Since considerably higher concentrations (greater 10(-4) M) of these compounds were required to produce a significant inhibition of c-AMP phosphodiesterase activity in adipose tissue, it is proposed that the lipolytic response is a result of stereoselective interaction of these tetrahydroisoquinolines at the level of membrane-bound adenylate cyclase.
Asunto(s)
Agonistas Adrenérgicos beta/farmacología , Isoquinolinas/farmacología , Receptores Adrenérgicos beta/efectos de los fármacos , Receptores Adrenérgicos/efectos de los fármacos , Tejido Adiposo/análisis , Tejido Adiposo/efectos de los fármacos , Animales , AMP Cíclico/análisis , Femenino , Cobayas , Corazón/efectos de los fármacos , Masculino , Fentolamina/farmacología , Propranolol/farmacología , Ratas , Estereoisomerismo , Tráquea/efectos de los fármacosRESUMEN
Ligand binding studies with WB 4101 revealed that the rat aorta contains both the alpha 1a- and alpha 1b-adrenoceptor subtypes. Results obtained following treatment with the irreversible antagonists phenoxybenzamine, chlorethylclonidine or SZL-49 (4-amino-6,7-dimethoxy-2-quinazolinyl-4-(2-bicyclo[2,2,2]octa-2,5- dienylcarbonyl-2-piperazine) suggest that there is a complex interaction between the alpha 1-adrenoceptor subtypes in the aorta. Chlorethylclonidine affects only the alpha 1b-adrenoceptor, whereas the predominant action of SZL-49 is on the alpha 1a-subtype. Chlorethylclonidine significantly inhibited the response to either methoxamine or phenylephrine, agents which are selective alpha 1a-adrenoceptor agonists. Following inactivation with either chlorethylclonidine or SZL-49, the response of the rat aorta to phenylephrine was only partially antagonized by either prazosin or WB 4101. SZL-49 also inhibited the response of the rat tail artery to electrical stimulation. The response of the tail artery obtained following inactivation with SZL-49 was effectively antagonized by prazosin. Phenylephrine, prazosin or WB 4101 afforded complete protection from chlorethylclonidine adrenoceptor inactivation, while these same ligands were only partially effective against SZL-49. Either SZL-49 or chlorethylclonidine significantly impaired the irreversible adrenoceptor blocking actions of phenoxybenzamine. These results suggest: (1) only the alpha 1a-adrenoceptor subtype appears to be associated with nerve terminals in the tail artery, (2) there may be a complex interaction between the alpha 1-adrenoceptor subtypes such that both receptors must be intact and functional to observe normal agonist and antagonist interactions, (3) there may be three sites of action for agonists associated with the rat aorta.
Asunto(s)
Receptores Adrenérgicos alfa/fisiología , Antagonistas Adrenérgicos alfa/farmacología , Animales , Aorta Torácica/metabolismo , Unión Competitiva , Clonidina/análogos & derivados , Clonidina/antagonistas & inhibidores , Clonidina/farmacología , Dioxanos/metabolismo , Técnicas In Vitro , Cinética , Masculino , Metoxamina/metabolismo , Músculo Liso Vascular/fisiología , Músculo Liso Vascular/ultraestructura , Fenoxibenzamina/farmacología , Fenilefrina/antagonistas & inhibidores , Prazosina/análogos & derivados , Prazosina/antagonistas & inhibidores , Prazosina/metabolismo , Prazosina/farmacología , Ratas , Ratas Endogámicas , Receptores Adrenérgicos alfa/clasificaciónRESUMEN
The effect of calcium (Ca2+) on the adenylate cyclase activity and calmodulin level of cerebral cortex was determined in pentobarbital dependent rats and age matched controls. Female Sprague-Dawley rats were made dependent and maintained on pentobarbital by eating a mixture of pentobarbital and rat chow (350 mg pentobarbital/30 g chow). Ca2+ activated then inhibited the adenylate cyclase activity associated with a 20,000 X g particulate fraction from pentobarbital dependent and age matched control rats. The values for one-half maximal stimulation and inhibition by Ca2+ did not differ significantly in either cortical preparation. However, the ability of Ca2+ to activate adenylate cyclase from pentobarbital dependent animals was significantly decreased (p less than 0.05) when compared to control animals. Pentobarbital (10(-4) - 10(-3) added to particulate fractions from naive control rats did not alter the ability of Ca2+ to activate adenylate cyclase. The calmodulin levels in the particulate fraction from pentobarbital dependent animals (30.2 +/- 6.7 ng calmodulin/mg protein) did not differ significantly when compared to control (33.0 +/- 4.7 ng/mg). By contrast, the calmodulin levels (37.9 +/- 5.9 ng/mg) in the 20,000 X g supernatant from cortex of pentobarbital dependent animals was significantly greater than the level in the supernatant from control animals (28.6 +/- 2.6 ng/mg). The ability of forskolin, dopamine, GTP or forskolin plus GTP (all at a concentration of 100 microM) to activate adenylate cyclase was significantly decreased in particulate preparations from pentobarbital dependent animals. In summary, our data show that alterations in calmodulin levels and a decreased responsivity of adenylate cyclase occur in animals physically dependent on pentobarbital.
Asunto(s)
Adenilil Ciclasas/análisis , Calmodulina/análisis , Corteza Cerebral/análisis , Pentobarbital , Trastornos Relacionados con Sustancias/metabolismo , Animales , Calcio/farmacología , Colforsina , Diterpenos/farmacología , Dopamina/farmacología , Femenino , Guanosina Trifosfato/farmacología , Guanilil Imidodifosfato/farmacología , Humanos , Ratas , Ratas EndogámicasRESUMEN
The effect of the calcium channel agonist BAY K 8644 on the ability of KCl and norepinephrine to induce contractions of rabbit aortic rings has been examined in Krebs-Henseleit buffer containing either 4.0 or 6.8 mM potassium. BAY K 8644 (10(-8) to 10(-6) M) alone induced slowly developing aortic contractures which were 10 (at 4.0 mM potassium) or 20 (at 6.8 mM potassium) percent of the maximum obtainable with norepinephrine. These contractions were not observed in every experiment, but were more likely to occur at 6.8 mM (71% at 10(-6) M BAY K 8644) when compared to 4.0 mM (31% at 10(-6) M BAY K 8644) potassium buffer. BAY K 8644, in either potassium buffer, induced a statistically significant shift to the left in the norepinephrine dose-response curve. The norepinephrine dose-response curve was significantly curvilinear in the presence of 3 X 10(-8) M BAY K 8644 (6.8 mM potassium) and 10(-6) M BAY K 8644 (4.0 mM potassium). Similarly, BAY K 8644 induced sinistral shifts in the KCl dose-response curve with a curvilinear function observed at 3 X 10(-7) M BAY K 8644. These data show that BAY K 8644 is capable of inducing aortic contractures at potassium concentrations significantly lower than previously reported. Furthermore, BAY K 8644 facilitates opening of calcium channels by either potassium or norepinephrine. In contrast to others, our data indicates that BAY K 8644 can affect calcium channels activated by norepinephrine. Finally, our data suggest that the alpha and dihydropyridine receptors are capable of interacting and that occupation of one receptor can affect the action of a compound binding to the other receptor.
Asunto(s)
Contracción Muscular/efectos de los fármacos , Músculo Liso Vascular/fisiología , Nifedipino/análogos & derivados , Norepinefrina/farmacología , Cloruro de Potasio/farmacología , Ácido 3-piridinacarboxílico, 1,4-dihidro-2,6-dimetil-5-nitro-4-(2-(trifluorometil)fenil)-, Éster Metílico , Animales , Aorta/fisiología , Relación Dosis-Respuesta a Droga , Masculino , Nifedipino/farmacología , ConejosRESUMEN
The nature of the alpha 1 receptor associated with rabbit aorta has been examined in functional and receptor binding studies. In isolated aortic rings the dose-response curve for (-)metaraminol was not parallel to that of (-)epinephrine, (-)norepinephrine or (-)phenylephrine. Following inactivation of a portion of the alpha receptors with phenoxybenzamine, the occupancy versus response relationship for metaraminol, in contrast to the other test agonists, was biphasic. These results suggest the possibility that metaraminol interacts with different functional groups on the alpha 1 receptor than the other test agonists. In microsomes prepared from frozen aorta, metaraminol bound to two classes of sites (KH = 0.41 +/- 0.12 microM, KL = 39.1 +/- 7.1 microM) labelled by the selective alpha 1 antagonist [3H] prazosin. Similar binding characteristics were observed in microsomes prepared from aorta shipped in serum on ice or aorta from animals killed in our laboratory. Norepinephrine also bound to two sites on the alpha receptor in all three preparations tested (KH = 0.06 +/- 0.01 microM, KL = 5.09 +/- 2.4 microM; estimates from frozen aorta). The Scatchard plot of [3H]prazosin binding to microsomes prepared from frozen aorta was curvilinear. Estimates of the affinities and site densities were 49.6 +/- 15.3 pM and 44.8 +/- 11.8 pmol/gm protein and 1.0 +/- 0.2 and 43.8 +/- 17.4 pmol/gm for the high and low affinity sites, respectively. These data are consistent with the idea that there are subtypes of the alpha 1 receptor.
Asunto(s)
Músculo Liso Vascular/fisiología , Receptores Adrenérgicos alfa/fisiología , Animales , Aorta , Relación Dosis-Respuesta a Droga , Epinefrina/metabolismo , Epinefrina/farmacología , Masculino , Metaraminol/metabolismo , Metaraminol/farmacología , Microsomas/metabolismo , Contracción Muscular/efectos de los fármacos , Norepinefrina/metabolismo , Norepinefrina/farmacología , Fenilefrina/metabolismo , Fenilefrina/farmacología , Prazosina/metabolismo , Conejos , Receptores Adrenérgicos alfa/efectos de los fármacosAsunto(s)
Antagonistas Adrenérgicos beta , Isoquinolinas/farmacología , Tretoquinol/farmacología , Adenilil Ciclasas/metabolismo , Tejido Adiposo/metabolismo , Animales , Membrana Celular/enzimología , AMP Cíclico/metabolismo , Técnicas In Vitro , Metabolismo de los Lípidos , Masculino , Ratas , Tretoquinol/análogos & derivadosAsunto(s)
3',5'-AMP Cíclico Fosfodiesterasas/metabolismo , Proteínas de Unión al Calcio/farmacología , Calcio/metabolismo , Calmodulina/farmacología , Proteínas de la Membrana/metabolismo , Miocardio/metabolismo , Proteínas Quinasas/metabolismo , Retículo Sarcoplasmático/metabolismo , Animales , Transporte Biológico Activo/efectos de los fármacos , Bovinos , Perros , Activación Enzimática , Membranas Intracelulares/metabolismo , Cinética , Peso Molecular , Fosforilación , Retículo Sarcoplasmático/efectos de los fármacosAsunto(s)
Antagonistas Adrenérgicos beta , Corazón/efectos de los fármacos , Isoquinolinas/farmacología , Tretoquinol/farmacología , Animales , Dobutamina/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Técnicas In Vitro , Isoproterenol/farmacología , Masculino , Contracción Miocárdica/efectos de los fármacos , Conejos , Tretoquinol/análogos & derivadosRESUMEN
The adrenergic receptors play a key role in the modulation of sympathetic nervous system activity as well as a site of action for many therapeutic agents. The alpha1-adrenergic receptor subtypes (alpha1A-, alpha1B-, alpha1D) are the prime mediators of smooth muscle contraction and hypertrophic growth, but their characterization in both binding and function have lagged the other adrenergic family members. Although they are derived from a related ancestral gene and all nine adrenergic receptor family members bind the endogenous ligands, epinephrine and norepinephrine, with roughly similar affinities, there are major differences in the mode of binding, second messenger utilization, and physiological effects of the alpha1-subtypes compared with beta- or alpha2-subtypes. Here, we review the recent literature on aspects of its binding pocket and how it differs from the beta-adrenergic receptor paradigms. We also review the signaling components and aspects of its function and provide new insights into its roles in smooth muscle, growth, neurological, and cardiovascular function.
Asunto(s)
Receptores Adrenérgicos alfa 1/fisiología , Antagonistas Adrenérgicos alfa/metabolismo , Animales , Humanos , Receptores Adrenérgicos alfa 1/química , Receptores Adrenérgicos alfa 1/clasificación , Receptores Adrenérgicos alfa 1/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiologíaRESUMEN
High doses of lithium in animals and therapeutic doses of lithium in humans caused varied abnormalities in cardiac conduction including A-V block. Five cases of first degree A-V block in patients receiving therapeutic doses of lithium carbonate are reported.
Asunto(s)
Bloqueo Cardíaco/inducido químicamente , Litio/efectos adversos , Adulto , Femenino , Humanos , Litio/administración & dosificación , Litio/sangre , Carbonato de Litio , Masculino , Persona de Mediana EdadRESUMEN
The Ca2+-dependent regulation of the adenylate cyclase activity associated with microsomes isolated from bovine aortic smooth muscle has been studied. Calmodulin content of microsomal membranes employed in these studies was 80 +/- 14 ng/mg as determined by specific radioimmunoassay. In the absence of exogenous calmodulin, Ca2+ concentrations greater than 0.8 microM inhibited adenylate cyclase activity with one-half-maximal inhibition occurring at 2.5 microM Ca2+. In the presence of 5 or 9 microM bovine testis calmodulin, Ca2+ stimulated smooth muscle adenylate cyclase activity with one-half-maximal stimulation occurring at 0.2 microM for both 5 and 9 microM calmodulin. Calmodulin stimulation was observed between 0.1 and 0.8 microM Ca2+. Despite the presence of calmodulin, Ca2+ concentrations greater than 0.8 microM were inhibitory to smooth muscle adenylate cyclase activity. However, calmodulin reduced the sensitivity of the enzyme to inhibition by Ca2+. Trifluoperazine (100 microM) reversed both the calmodulin-dependent stimulation of cyclase activity and the calmodulin-induced decrease in sensitivity to the inhibitory actions of Ca2+. Trifluoperazine alone shifted the curve describing Ca2+ inhibition of cyclase activity to the left. The value of Ca2+ for one-half-maximal inhibition decreased from 2.9 to 1.2 microM. The trifluoperazine-induced shift was reversed by exogenous calmodulin. These data suggest: 1) Ca2+, at physiological concentrations, can stimulate as well as inhibit smooth muscle adenylate cyclase activity; 2) the stimulation of adenylate cyclase activity is mediated by calmodulin; 3) the Ca2+-calmodulin complex reduces the sensitivity of smooth muscle adenylate cyclase to the inhibitory actions of Ca2+; and 4) the level of calmodulin associated with smooth muscle adenylate cyclase may modulate the response (both stimulatory and inhibitory) of the enzyme to Ca2+.
Asunto(s)
Adenilil Ciclasas/metabolismo , Proteínas de Unión al Calcio/farmacología , Calcio/metabolismo , Calmodulina/farmacología , Músculo Liso/enzimología , Animales , Bovinos , Microsomas/enzimología , Trifluoperazina/farmacologíaRESUMEN
The interaction between activators of the calcium channel and the alpha 1-adrenoceptor has been studied in isolated rabbit aortic rings. The data obtained in these investigations are not consistent with the idea of a homogenous population of alpha 1-receptors which trigger contraction via a single pathway. Our results suggest that calcium channel activators reveal two modes of spasmogenic action for alpha 1-adrenoceptor agonists. Furthermore, we have shown that there may be multiple drug recognition sites on the alpha 1-receptor.
Asunto(s)
Agonistas alfa-Adrenérgicos/farmacología , Aorta/fisiología , Agonistas de los Canales de Calcio/farmacología , Ácido 3-piridinacarboxílico, 1,4-dihidro-2,6-dimetil-5-nitro-4-(2-(trifluorometil)fenil)-, Éster Metílico/farmacología , Animales , Sitios de Unión , Catecolaminas/metabolismo , Relación Dosis-Respuesta a Droga , Neurotransmisores/metabolismo , Conejos , Reserpina/farmacologíaRESUMEN
The isomers and racemate of trimetoquinol [TMQ; 6-7-dihydroxy-1-(3',4',5'-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline] as well as N-(3',4',5'-trimethoxyphenethyl)dopamine were all shown to be effective at promoting glycerol release from rat epididymal fat tissue. The rank order of potency observed for these compounds was (-)-TMQ greater than or equal to (+/-)-TMQ greater than greater than (+)-TMQ = N-(3',4',5-trimethoxyphenethyl)dopamine. (+/-)-TMQ and (-)-TMQ were the only agents capable of producing a maximal lipolytic response. None of the compounds tested were able to exhibit significant c-AMP phosphodiesterase inhibition. This study is the first report which shows that the beta-adrenoceptor activity of the isomers of TMQ does not correlate with an inhibition of c-AMP phosphodiesterase. An alternate mechanism of action for these compounds is proposed.